A former Bayer medical affairs lead explains why data-quality decisions land with whoever controls the budget, not whoever understands the data.
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
ON-DEMAND WEBINARS
This presentation focuses on the scope and utility of the National Health and Nutrition Examination Survey, a program of studies designed to assess the health status of individuals in the United States.
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
The most difficult clinical research just became more challenging. Learn tactics on how teams can simplify oncology research while solving new and old issues.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1197856275 patient recruitment, enrollment, DCT]( "Enhancing The Patient Journey In Clinical Trials")
Enhancing The Patient Journey In Clinical TrialsUtilize supportive data to overcome the challenges of implementing a patient-focused approach to clinical trials and enhance your trial outcomes, advancing research and improving the patient journey.
-
![GettyImages-1394355488 data]( "The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny")
The Significance Of Quality Data In Meeting FDA Regulatory ScrutinyData Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.
-
![workflow improvement-bottlenecking control-GettyImages-1451272908]( "Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)?")
Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)?Real-time data streaming to regulators is a bold step, but true clinical acceleration requires solving site-level bottlenecks and data silos to reduce the administrative burden on research.
-
![GettyImages-1194783103 eCOA ps]( "eCOA Predictions For 2022")
eCOA Predictions For 2022Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
![Grandmother-and-adult-granddaughter-speak-with-HCP-in-clinic-2-(high-res)-(1)]( "How Protocol Design Decisions Shape Recruitment, Data Quality & Study Startup")
How Protocol Design Decisions Shape Recruitment, Data Quality & Study StartupProtocol design directly affects recruitment, data quality, and startup speed. Clear workflows, streamlined criteria, and early alignment reduce delays, amendments, and improve reliable study execution.
-
![Doctor Using Digital Tablet GettyImages-1530254515]( "How Vanguard Clinical Harnesses CDMS/EDC For Faster Results")
How Vanguard Clinical Harnesses CDMS/EDC For Faster ResultsUncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
![GettyImages-182487080 FDA]( "Unlocking The Power Of Real-World Evidence In FDA Submissions")
Unlocking The Power Of Real-World Evidence In FDA SubmissionsUnderstand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.
-
![fact and myth-GettyImages-1537534263]( "The Top 5 Myths About eCOA In 2025")
The Top 5 Myths About eCOA In 2025Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover the top five myths and misconceptions about eCOAs in 2025 so your clinical teams can make evidence-based decisions.
-
![Partners-Getty- 871491468]( "A System For Better Vendor Relationships")
A System For Better Vendor RelationshipsShift your clinical trial strategy with zero-cost habits that build trust, protect trial continuity, and transform routine supplier management into resilient, high-performing partnerships.
-
![audit]( "12 Items Auditors Look For When Reviewing An Investigator Site File")
12 Items Auditors Look For When Reviewing An Investigator Site FileMaintaining complete, compliant documentation on top of managing the complex processes and interactions of clinical trial conduct can be challenging. Explore twelve items to help you prepare your ISF for an audit.
RECENT NEWSLETTERS
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
